Status:
UNKNOWN
HPV Prevalence in 16-20 Year Old Males
Lead Sponsor:
Laval University
Conditions:
HPV Infection
Eligibility:
MALE
16-20 years
Brief Summary
In Quebec, 18 birth cohorts of girls were vaccinated against HPV (aged 9 to 29 years in 2020). With an observed vaccination coverage of \>80% an important herd effect might be expected. This study aim...
Detailed Description
An HPV immunization program is in place in Quebec since 2008. By 2020 18 birth cohorts of girls were eligible for vaccination. Vaccine uptake with at least one dose of vaccine was \>80%. With such a h...
Eligibility Criteria
Inclusion
- unvaccinated against HPV
- sexually active
Exclusion
- received an HPV vaccine
- non sexually active
Key Trial Info
Start Date :
February 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
681 Patients enrolled
Trial Details
Trial ID
NCT04297670
Start Date
February 20 2020
End Date
December 31 2020
Last Update
March 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laval University Research Hospital Center
Québec, Canada, G1E7G9